Digitisation | June 21, 2023
Verix acquires start-up.ai
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
The start-up.ai team will be integrated into Verix, boosting its innovative Life Science AI capabilities
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
This patent-pending, high-efficiency chromatography media is used for the purification of novel peptide-based pharmaceuticals in the GLP-1 agonist class including type 2 diabetes and obesity treatments
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Subscribe To Our Newsletter & Stay Updated
